AT

Athersys

- NASDAQ:ATHX
Last Updated 2024-04-16
  • Athersys, a biopharmaceutical company, discovers and develops therapeutic products for the treatment of several disease indications.

  • Locations

    • Cleveland OH

  • Total Funding (USD)

    65.1 million

  • Industries

    Real Estate, Mobile Apps, Cyber Security

  • Security

    Type: ORD
    CUSIP: 04744L106
    ISIN: US04744L1061
Filter date
All
Bookmark Created by Last updated
There were no results found.
Filter date
All
Article Author Published
There were no results found.

Request a demo to view additional historical data, and much more.

Request Demo